The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML). uri icon

authors

  • Elliot, Kathleen
  • Tooze, Janet A
  • Geller, Rachel
  • Powell, Bayard L
  • Pardee, Timothy S
  • Ritchie, Ellen
  • Kennedy, LeAnne
  • Kate Callahan, MD, MS
  • Klepin, Heidi D

publication date

  • January 1, 2014